IllnessPlasminogen-Aktivatorinhibitor 1-Defizienz; auch Differentialdiagnose
Summary
Short information
Comprehensive differential diagnostic panel for Plasminogen activator inhibitor 1 deficiency comprising 1 or altogether 14 curated genes according to the clinical signs
ID
KP3645
Number of genes
14
Accredited laboratory test
Examined sequence length
1,3 kb (Core-/Core-canditate-Genes)
36,7 kb (Extended panel: incl. additional genes)
36,7 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
- EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications
NGS +
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
SERPINE1 | 1209 | NM_000602.5 | AD, AR | |
ANO6 | 2733 | NM_001025356.3 | AR | |
F10 | 1467 | NM_000504.4 | AR | |
F13A1 | 2199 | NM_000129.4 | AD, AR | |
F13B | 1986 | NM_001994.3 | AR | |
F2 | 1869 | NM_000506.5 | AD, AR | |
F5 | 6675 | NM_000130.5 | AD, AR | |
GP1BA | 1959 | NM_000173.7 | AD, AR | |
GP1BB | 621 | NM_000407.5 | AR | |
GP9 | 534 | NM_000174.5 | AR | |
ITGA2B | 3120 | NM_000419.5 | AD, AR | |
ITGB3 | 2367 | NM_000212.3 | AD, AR | |
SERPINF2 | 1476 | NM_000934.4 | AR | |
VWF | 8442 | NM_000552.5 | AR, AD |
Informations about the disease
Clinical Comment
Hemorrhagic disorder due to a constitutional haemostatic factors defect characterized by premature lysis of hemostatic clots and a moderate bleeding tendency
Synonyms
- Alias: Congenital PAI-1 deficiency
- Alias: Hyperfibrinolysis due to PAI1 deficiency
- Allelic: Budd-Chiari syndrome
- Allelic: Myocardial infarction, protection against (F13A1)
- Allelic: Myocardial infarction, susceptibility to (ITGB3)
- Allelic: Nonarteritic anterior ischemic optic neuropathy, susceptibility to (GP1BA)
- Allelic: Pregnancy loss, recurrent, susceptibility to, 1 (F5)
- Allelic: Pregnancy loss, recurrent, susceptibility to, 2 (F2)
- Allelic: Purpura, posttransfusion (ITGB3)
- Allelic: Stroke, ischemic, susceptibility to (F2)
- Allelic: Stroke, ischemic, susceptibility to (F5)
- Allelic: Thrombophilia, susceptibility to, due to factor V Leiden (F5)
- Allelic: Transcription of plasminogen activator inhibitor, modulator of (SERPINE1)
- Allelic: Venous thrombosis, protection against (F13A1)
- Alpha-2-plasmin inhibitor deficiency (SERPINF2)
- Bernard-Soulier syndrome, type A1, AR (GP1BA)
- Bernard-Soulier syndrome, type A2, AD (GP1BA)
- Bernard-Soulier syndrome, type B (GP1BB)
- Bernard-Soulier syndrome, type C (GP9)
- Bleeding disorder, platelet-type, 16, AD (ITGA2B)
- Bleeding disorder, platelet-type, 16, AD (ITGB3)
- Dysprothrombinemia (F2)
- Factor V deficiency (F5)
- Factor X deficiency (F10)
- Factor XIIIA deficiency (F13A1)
- Factor XIIIB deficiency (F13B)
- Giant platelet disorder, isolated (GP1BB)
- Glanzmann thrombasthenia (ITGA2B)
- Glanzmann thrombasthenia (ITGB3)
- Hypoprothrombinemia (F2)
- Plasminogen activator inhibitor-1 deficiency (SERPINE1)
- Scott syndrome; bleeding disorder, platelet-type, 7 (ANO6)
- Thrombocytopenia, neonatal alloimmune (ITGB3)
- Thrombocytopenia, neonatal alloimmune, BAK antigen related (ITGA2B)
- Thrombophilia due to activated protein C resistance (F5)
- Thrombophilia due to thrombin defect (F2)
- von Willebrand disease, platelet-type (GP1BA)
- von Willebrand disease, type 1, 2A, 2B, 2M, 2N, 3 (VWF)
Heredity, heredity patterns etc.
- AD
- AR
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
D68.2-
Bioinformatics and clinical interpretation
No text defined